SCHEMBL6925221

SCHEMBL6925221

Oc1c(Cl)ccc2c1c1ccccc1n2Cc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.59
P2RX4 Q99571 1/20 0.53
MEN1 O00255 6/20 0.49
KMT2A Q03164 6/20 0.49
ALDH1A1 P00352 6/20 0.49
MAPT P10636 3/20 0.49
KDM4E B2RXH2 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
MAPK1 P28482 2/20 0.48
SRC P12931 1/20 0.47
CCR2 P41597 2/20 0.45
PGR P06401 1/20 0.44
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
LMNA P02545 1/20 0.44
HPGD P15428 1/20 0.44
UTS2R Q9UKP6 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6921173 0.80 CYP19A1 (0.65) CYP19A1P2RX4MEN1KMT2AALDH1A1
SCHEMBL16186875 0.76 CYP19A1 (0.65) CYP19A1P2RX4MEN1KMT2AALDH1A1
SCHEMBL30007452 0.76 CYP19A1 (1.00) CYP19A1P2RX4MEN1KMT2AALDH1A1
SCHEMBL151053 0.76 CYP19A1 (1.00) CYP19A1P2RX4MEN1KMT2AALDH1A1
SCHEMBL6919987 0.74 CYP19A1 (0.49) CYP19A1P2RX4MEN1KMT2AALDH1A1
Bromide SCHEMBL28888744 0.74 CYP19A1 (0.95) CYP19A1P2RX4MEN1KMT2AALDH1A1
Ammonia Solution, Strong SCHEMBL29210102 0.74 CYP19A1 (0.95) CYP19A1P2RX4MEN1KMT2AALDH1A1
SCHEMBL9398256 0.74 CYP19A1 (0.95) CYP19A1P2RX4MEN1KMT2AALDH1A1
SCHEMBL8920050 0.74 CYP19A1 (0.61) CYP19A1P2RX4MEN1KMT2AALDH1A1
SCHEMBL29588112 0.74 CYP19A1 (0.56) CYP19A1P2RX4MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1169789-C Aminoalkoxy carbazoles for the treatment of CNS diseases 法玛西雅厄普约翰美国公司 2004-10-06 CN disclosed
US-6514968-B1 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising PHARMACIA & UPJOHN COMPANY 2003-02-04 US disclosed
CN-1372547-A Aminoalkoxy carbazoles for the treatment of CNS diseases UPJOHN CO (US) 2002-10-02 CN disclosed
EP-1210329-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-06-05 EP disclosed
WO-2001017963-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2001-03-15 WO disclosed